# PRISMA 2020 Checklist

> Preferred Reporting Items for Systematic Reviews and Meta-Analyses
> Reference: Page MJ, et al. BMJ 2021;372:n71. https://doi.org/10.1136/bmj.n71

---

## Title

| Item | Checklist Item | Reported (Y/N) | Page |
|------|----------------|----------------|------|
| 1 | Identify the report as a systematic review | | |

---

## Abstract

| Item | Checklist Item | Reported (Y/N) | Page |
|------|----------------|----------------|------|
| 2 | Provide a structured abstract including: background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions, systematic review registration number | | |

---

## Introduction

| Item | Checklist Item | Reported (Y/N) | Page |
|------|----------------|----------------|------|
| 3 | **Rationale**: Describe the rationale for the review in the context of existing knowledge | | |
| 4 | **Objectives**: Provide an explicit statement of the objective(s) or question(s) the review addresses | | |

---

## Methods

| Item | Checklist Item | Reported (Y/N) | Page |
|------|----------------|----------------|------|
| 5 | **Eligibility criteria**: Specify the inclusion and exclusion criteria for the review and how studies were grouped for syntheses | | |
| 6 | **Information sources**: Specify all databases, registers, websites, organisations, reference lists and other sources searched or consulted. Specify the date when each source was last searched or consulted | | |
| 7 | **Search strategy**: Present the full search strategies for all databases, registers and websites, including any filters and limits used | | |
| 8 | **Selection process**: Specify methods used to decide whether a study met inclusion criteria, including how many reviewers screened each record and each full-text, whether they worked independently, and if applicable, details of automation tools used | | |
| 9 | **Data collection process**: Specify methods for data collection, including how many reviewers collected data, whether they worked independently, any processes for obtaining or confirming data from study investigators, and if applicable, details of automation tools used | | |
| 10a | **Data items**: List and define all outcomes for which data were sought. Specify whether all results that were compatible with each outcome domain were sought, and if not, methods used to decide which results to collect | | |
| 10b | **Data items**: List and define all other variables for which data were sought. Describe any assumptions made about missing or unclear information | | |
| 11 | **Study risk of bias assessment**: Specify methods used to assess risk of bias in included studies, including details of the tool(s) used, how many reviewers assessed each study and whether they worked independently, and if applicable, details of automation tools used | | |
| 12 | **Effect measures**: Specify for each outcome the effect measure(s) used in the synthesis or presentation of results | | |
| 13a | **Synthesis methods**: Describe the processes used to decide which studies were eligible for each synthesis | | |
| 13b | **Synthesis methods**: Describe any methods required to prepare the data for synthesis if applicable | | |
| 13c | **Synthesis methods**: Describe any methods used to tabulate or visually display results of individual studies and syntheses | | |
| 13d | **Synthesis methods**: Describe any methods used to synthesize results and provide a rationale for the choice(s). If meta-analysis was performed, describe the model(s), method(s) to identify the presence and extent of statistical heterogeneity, and software package(s) used | | |
| 13e | **Synthesis methods**: Describe any methods used to explore possible causes of heterogeneity among study results | | |
| 13f | **Synthesis methods**: Describe any sensitivity analyses conducted to assess robustness of the synthesized results | | |
| 14 | **Reporting bias assessment**: Describe any methods used to assess risk of bias due to missing results in a synthesis (arising from reporting biases) | | |
| 15 | **Certainty assessment**: Describe any methods used to assess certainty (or confidence) in the body of evidence for an outcome | | |

---

## Results

| Item | Checklist Item | Reported (Y/N) | Page |
|------|----------------|----------------|------|
| 16a | **Study selection**: Describe the results of the search and selection process, ideally using a flow diagram | | |
| 16b | **Study selection**: Cite studies that might appear to meet inclusion criteria but were excluded, and explain why | | |
| 17 | **Study characteristics**: Cite each included study and present its characteristics | | |
| 18 | **Risk of bias in studies**: Present assessments of risk of bias for each included study | | |
| 19 | **Results of individual studies**: For all outcomes, present for each study (a) summary statistics for each group and (b) an effect estimate and its precision, ideally using structured tables or plots | | |
| 20a | **Results of syntheses**: For each synthesis, briefly summarise the characteristics and risk of bias among contributing studies | | |
| 20b | **Results of syntheses**: Present results of all statistical syntheses conducted. If meta-analysis was done, present for each the summary estimate and its precision and measures of statistical heterogeneity. If comparing groups, describe the direction of the effect | | |
| 20c | **Results of syntheses**: Present results of all investigations of possible causes of heterogeneity among study results | | |
| 20d | **Results of syntheses**: Present results of all sensitivity analyses conducted to assess the robustness of the synthesized results | | |
| 21 | **Reporting biases**: Present assessments of risk of bias due to missing results for each synthesis assessed | | |
| 22 | **Certainty of evidence**: Present assessments of certainty in the body of evidence for each outcome assessed | | |

---

## Discussion

| Item | Checklist Item | Reported (Y/N) | Page |
|------|----------------|----------------|------|
| 23a | **Discussion**: Provide a general interpretation of the results in the context of other evidence | | |
| 23b | **Discussion**: Discuss any limitations of the evidence included in the review | | |
| 23c | **Discussion**: Discuss any limitations of the review processes used | | |
| 23d | **Discussion**: Discuss implications of the results for practice, policy, and future research | | |

---

## Other Information

| Item | Checklist Item | Reported (Y/N) | Page |
|------|----------------|----------------|------|
| 24a | **Registration and protocol**: Provide registration information including register name and registration number, or state not registered | | |
| 24b | **Registration and protocol**: Indicate where the review protocol can be accessed, or state not available | | |
| 24c | **Registration and protocol**: Describe and explain any amendments to information provided at registration or in the protocol | | |
| 25 | **Support**: Describe sources of financial or non-financial support for the review, and the role of funders or sponsors | | |
| 26 | **Competing interests**: Declare any competing interests of review authors | | |
| 27 | **Availability of data, code and materials**: Report which of the following are publicly available and where: template data collection forms, data extracted from included studies, data used for analyses, analytic code, any other materials used in the review | | |

---

## PRISMA for Abstracts Checklist

For conference abstracts or brief reports:

| Section | Items to Include |
|---------|-----------------|
| Title | Identify as systematic review/meta-analysis |
| Objectives | State primary objective |
| Data sources | Databases searched, date range |
| Study eligibility | Inclusion criteria, study types |
| Participants | Target population |
| Interventions | What was studied |
| Study appraisal | Risk of bias assessment method |
| Synthesis methods | How studies were combined |
| Results | Number of studies, participants, summary effect with CI |
| Limitations | Key limitations |
| Conclusions | General interpretation |
| Funding | Source of funding |
| Registration | PROSPERO or other registration number |

---

## PRISMA-S Extension (Search Reporting)

Additional items for comprehensive search reporting:

| Item | Description |
|------|-------------|
| S1 | Database name and platform |
| S2 | Multi-database searching approach |
| S3 | Study registries searched |
| S4 | Online resources and grey literature |
| S5 | Citation searching methods |
| S6 | Contacts with study authors |
| S7 | Search strategies for each database |
| S8 | Limits and filters used |
| S9 | Search validation process |
| S10 | Peer review of search strategy |
| S11 | Total records and deduplication |
| S12 | Search strategy amendments |

---

## PRISMA-ScR Extension (Scoping Reviews)

Modified items for scoping reviews:

| Item | Modification |
|------|-------------|
| Title | Identify as scoping review |
| Protocol | PROSPERO or OSF registration |
| Eligibility | May include broader criteria |
| Risk of bias | Optional for scoping reviews |
| Synthesis | Typically narrative, charting data |
| Results | Emphasis on mapping evidence |

---

## Flow Diagram Requirements

The PRISMA 2020 flow diagram must include:

### Identification
- Records from databases (with database names and counts)
- Records from registers
- Records from other sources (citation searching, etc.)
- Records removed before screening (duplicates, automation)

### Screening
- Records screened
- Records excluded
- Reports sought for retrieval
- Reports not retrieved (with reasons)
- Reports assessed for eligibility
- Reports excluded (with reasons by category)

### Included
- Studies included in review
- Reports of included studies
- Studies in quantitative synthesis (if applicable)

### Template

```
Identification:
├── Databases (n = X)
│   ├── Database 1 (n = )
│   ├── Database 2 (n = )
│   └── Database 3 (n = )
├── Registers (n = Y)
└── Other sources (n = Z)
    ├── Citation searching (n = )
    ├── Websites (n = )
    └── Organizations (n = )

Records removed before screening:
├── Duplicates (n = )
└── Automation (n = )

Screening:
├── Records screened (n = )
├── Records excluded (n = )
├── Reports sought (n = )
├── Reports not retrieved (n = )
├── Reports assessed (n = )
└── Reports excluded (n = )
    ├── Reason 1 (n = )
    ├── Reason 2 (n = )
    └── Reason 3 (n = )

Included:
├── Studies in review (n = )
└── Studies in meta-analysis (n = )
```

---

## Quick Reference: Minimum PRISMA Compliance

For rapid reviews or resource-limited contexts, prioritize these items:

1. **Item 1**: Title identifies as systematic review
2. **Item 4**: Clear objectives
3. **Item 6**: Information sources listed
4. **Item 7**: Search strategy presented
5. **Item 16a**: Flow diagram included
6. **Item 17**: Study characteristics table
7. **Item 18**: Risk of bias assessment
8. **Item 20b**: Synthesis results
9. **Item 23a-d**: Discussion of findings and limitations
10. **Item 24a**: Registration information

---

## External Resources

| Resource | URL |
|----------|-----|
| PRISMA Statement | http://www.prisma-statement.org/ |
| PRISMA 2020 Paper | https://doi.org/10.1136/bmj.n71 |
| PRISMA Flow Diagram Generator | http://prisma.thetacollaborative.ca/ |
| PRISMA-P (Protocols) | https://doi.org/10.1136/bmj.g7647 |
| PRISMA-ScR (Scoping) | https://doi.org/10.7326/M18-0850 |
| PRISMA-S (Search) | https://doi.org/10.1186/s13643-020-01542-z |
